Novavax, Inc. : Novavax NanoFlu(TM) Vaccine Demonstrates Improved Immune Responses Compared to Egg-Based, High-Dose Flu Vaccine

Go back to Novavax, Inc. : Novavax NanoFlu(TM) Vaccine Demonstrates Improved Immune Responses Compared to Egg-Based, High-Dose Flu Vaccine
Novavax, Inc. (NASDAQ: NVAX) Delayed: 10.62 +0.51 (5.04%)
Previous Close $10.11    52 Week High $9.23 
Open $10.38    52 Week Low $1.16 
Day High $10.70    P/E N/A 
Day Low $10.21    EPS $-0.30 
Volume 3,497,725       

Novavax, Inc. (NASDAQ: NVAX) Delayed: 10.62 +0.51 (5.04%)
Previous Close $10.11    52 Week High $9.23 
Open $10.38    52 Week Low $1.16 
Day High $10.70    P/E N/A 
Day Low $10.21    EPS $-0.30 
Volume 3,497,725